Frazier Life Sciences Public Fund, L.P. 13D and 13G filings for Mereo BioPharma Group plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 1:39 pm Sale | 2025-06-30 | 13G | Mereo BioPharma Group plc MREO | Frazier Life Sciences Public Fund, L.P. | 32,430,690 4.100% | -7,918,625 (-19.63%) | Filing |
| 2025-04-04 12:39 pm Purchase | 2025-04-01 | 13G | Mereo BioPharma Group plc MREO | Frazier Life Sciences Public Fund, L.P. | 40,349,315 5.100% | 40,349,315 (New Position) | Filing |